Denali Therapeutics Down After Proposing To Sell $250 Million Of Shares

On:

Shares of Denali Therapeutics Inc. (DNLI) are falling more than 9% Wednesday morning at $29.60.

The company today said it proposes offer for sale of $250 million of shares.

DNLI has traded in the range of $20.24-$56.08
in the last 52 weeks.

Source: Read Full Article

Lates News:
  1. ARK’s Cathie Wood Says Bitcoin’s Upsurge As Global Banks Roil Will Attract New Institutional Investors In Droves
  2. Crawling Now, Sprinting Later: Analyst Foresees Major Bitcoin Rally
  3. Teledyne Drops As Profit Outlook Comes In Below View
  4. Crypto Analyst: ‘This Is Historically the Optimal Time To Allocate to Bitcoin’
  5. ETF Analyst Bullish on US Spot Bitcoin ETF Success, Drawing from Canada’s 60% Growth